The functional impact of adding salmeterol and tiotropium in patients with stable COPD

Respiratory Medicine

Volumn 98, Issue 12, 2004, Pages 1214-1221

  Cazzola, M ^a   Centanni, S ^b   Santus, P ^b   Verga, M ^b   Mondoni, M ^b   di Marco, F ^b   Matera, M G ^c  

^a CARDARELLI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Combination therapy; COPD; Salmeterol; Tiotropium

Indexed keywords

SALMETEROL; TIOTROPIUM BROMIDE;

AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; MONOTHERAPY; MULTIPLE DRUG DOSE; OUTPATIENT; PILOT STUDY; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ALBUTEROL; ANTHROPOMETRY; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; MALE; METERED DOSE INHALERS; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; VITAL CAPACITY;

EID: 8644251968     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.05.003     Document Type: Article

References (24)

1. Tashkin D.P. Cooper C.B. The role of long-acting bronchodilators in the management of stable COPD Chest 125 2004 249-259
2. Pauwels R.A. Buist A.S. Calverley P.M.A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (gold) workshop summary Am J Respir Crit Care Med 163 2001 1256-1276
3. Cazzola M. Di Marco F. Santus P. et al. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD Pulm Pharmacol Ther 17 2004 35-39
4. 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: Is combination therapy justified? Curr Opin Pharmacol 3 2003 270-276
5. Cazzola M. Matera M.G. Long-acting bronchodilators are the first-choice option for the treatment of stable COPD Chest 125 2004 9-11
6. Littner M.R. Ilowite J.S. Tashkin D.P. et al. Long-acting bronchodilation with once daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 1136-1142
7. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136:1285-98
8. Koch G.G. The use of nonparametric methods in the statistical analysis of the two period change-over design Biometrics 28 1972 577-584
9. Cazzola M. Spina D. Matera M.G. The use of bronchodilators in stable chronic obstructive pulmonary disease Pulm Pharmacol Ther 10 1997 129-144
10. Wessler I. Reinheimer T. Brunn G. et al. β-adrenoceptors mediate inhibition of [3 H]-acetylcholine release from the isolated rat and guinea-pig trachea: Role of the airway mucosa and prostaglandins Br J Pharmacol 113 1994 1221-1230
11. Brichetto L. Song P. Crimi E. et al. Modulation of cholinergic responsiveness through the β-adrenoceptor signal transmission pathway in bovine trachealis J Appl Physiol 95 2003 735-741
12. Combivent Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, A combination of ipratropium and albuterol is more effective than either agent alone. Chest 1994;105:1411-9
13. Ikeda A. Nishimura K. Koyama H. et al. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD. Comparison with ipratropium bromide alone Chest 107 1995 401-405
14. Dorinsky P.M. Reisner C. Ferguson G.T. et al. The combination of ipratropium, albuterol optimizes pulmonary function reversibility testing in patients with COPD Chest 115 1999 966-971
15. Siafakas N.M. Vermiere P. Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): the European respiratory society task force Eur Respir J 8 1995 1398-1420
16. American Thoracic Society. Standards for the diagnosis, care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-121
17. BTS guidelines for the management of chronic obstructive pulmonary disease: The COPD Guideline Group of the Standards of Care Committee of the BTS. Thorax 1997;52(suppl. 5):S1-28
18. D'Urzo A.D. De Salvo M.C. Ramirez-Rivera A. et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: a 3-week, randomized, double-blind, within-patient, multicenter study Chest 119 2001 1347-1356
19. Takahashi T. Belvisi M.G. Patel H. et al. Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways Am J Respir Crit Care Med 150 1994 1640-1645
20. Anderson P. Lötvall J. Linden A. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro Lung 174 1996 159-170
21. Ethier M.F. Dextradeur T. Schaefer O.P. et al. Effects of salmeterol on muscarinic inhibition of adenylyl cyclase in bovine trachealis cells Life Sci 67 2000 2753-2758
22. 2-sympathomimetics contribute to their relaxant effects in airway smooth muscle cells? Pulm Pharmacol Ther 11 1998 253-261
23. van Noord J.A. Smeets J.J. Custers F.L. et al. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease Eur Respir J 19 2002 639-644
24. Celli B. ZuWallack R. Wang S. et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes Chest 124 2003 1743-1748